Insider trading

Period: 120 months Stock: ALKS Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

26 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

26 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

26 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

26 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
26 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
26 decisions over 120 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

26 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 Aug 2026
Sold at will
$2.24M 44,472 at 50.35
74.3%
Sold half or more
29 May 2026
Parisi Samuel Joseph VP, Finance (Interim PAO)
Sold at will
$687.01K 16,217 at 42.36
67.8%
Sold half or more
13 Feb 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan 2×
$5.13M 144,419 at 35.53
71.4%
Sold half or more
12 Feb 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan 2×
$6.72M 204,921 at 32.78
78.0%
Sold half or more
30 Jan 2025
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan
$3.23M 100,918 at 32.05
69.5%
Sold half or more
9 Dec 2024
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold on a plan
$1.96M 61,151 at 32.07
56.2%
Sold half or more
9 May 2023
Wysenski Nancy Director
Sold on a plan
$1.29M 41,250 at 31.24
72.3%
Sold half or more
14 Nov 2022
Daglio David Angelo Jr. Director · indirect
Bought
$815.73K 35,000 at 23.31
77.8%
First buy on file
9 Jun 2021
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold, plan not stated
$21.70K 882 at 24.60
100%
Sold half or more
15 Apr 2021
Hopkinson Craig C. EVP R&D, Chief Medical Officer
Sold, plan not stated
$570.29K 28,920 at 19.72
100%
Sold half or more
1 Oct 2020
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$332.26K 20,000 at 16.61
74.1%
Sold half or more
24 Feb 2020
Wysenski Nancy Director · indirect
Bought
$136.37K 6,940 at 19.65
161%
First buy on file
1 Apr 2019
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$36.64K 1,000 at 36.64
100%
Sold half or more
1 Mar 2019
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$33.48K 1,000 at 33.48
100%
Sold half or more
1 Feb 2019
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$32.73K 1,000 at 32.73
100%
Sold half or more
4 Jan 2019
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$30.00K 1,000 at 30.00
100%
Sold half or more
3 Dec 2018
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$36.45K 1,000 at 36.45
100%
Sold half or more
2 Nov 2018
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$37.51K 1,000 at 37.51
100%
Sold half or more
1 Oct 2018
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$42.42K 1,000 at 42.42
100%
Sold half or more
4 Sep 2018
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$44.58K 1,000 at 44.58
100%
Sold half or more
1 Aug 2018
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$43.68K 1,000 at 43.68
100%
Sold half or more
3 Jul 2018
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$41.86K 1,000 at 41.86
100%
Sold half or more
1 Jun 2018
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$47.34K 1,000 at 47.34
100%
Sold half or more
1 May 2018
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$44.32K 1,000 at 44.32
100%
Sold half or more
2 Apr 2018
MITCHELL PAUL J Director · indirect
Sold, plan not stated
$46.75K 1,000 at 46.75
100%
Sold half or more
10 Nov 2016
BREYER ROBERT A Director
Sold, plan not stated
$1.20M 20,000 at 60.00
56.9%
Sold half or more
Showing 1–26 of 26.